| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Carboxypeptidase B2 |
|---|
| Ligand | BDBM50144323 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_206146 |
|---|
| IC50 | 1500±n/a nM |
|---|
| Citation |  Nantermet, PG; Barrow, JC; Lindsley, SR; Young, M; Mao, SS; Carroll, S; Bailey, C; Bosserman, M; Colussi, D; McMasters, DR; Vacca, JP; Selnick, HG Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group. Bioorg Med Chem Lett14:2141-5 (2004) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Carboxypeptidase B2 |
|---|
| Name: | Carboxypeptidase B2 |
|---|
| Synonyms: | CBPB2_HUMAN | CPB2 | CPU | Carboxypeptidase B2 | Carboxypeptidase B2 isoform A | Carboxypeptidase U | Plasma carboxypeptidase B | TAFI | Thrombin-activable fibrinolysis inhibitor | pCPB |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 48432.74 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q96IY4 |
|---|
| Residue: | 423 |
|---|
| Sequence: | MKLCSLAVLVPIVLFCEQHVFAFQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTAD
LIVKKKQVHFFVNASDVDNVKAHLNVSGIPCSVLLADVEDLIQQQISNDTVSPRASASYY
EQYHSLNEIYSWIEFITERHPDMLTKIHIGSSFEKYPLYVLKVSGKEQAAKNAIWIDCGI
HAREWISPAFCLWFIGHITQFYGIIGQYTNLLRLVDFYVMPVVNVDGYDYSWKKNRMWRK
NRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNI
NQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKISKNTRYTHGHGSE
TLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLLPERYIKPTCREAFAAVSKIAWHVI
RNV
|
|
|
|---|
| BDBM50144323 |
|---|
| n/a |
|---|
| Name | BDBM50144323 |
|---|
| Synonyms: | 3-(6-Amino-4-methyl-pyridin-3-yl)-2-(1H-imidazol-4-yl)-propionic acid | CHEMBL304532 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C12H14N4O2 |
|---|
| Mol. Mass. | 246.2652 |
|---|
| SMILES | Cc1cc(N)ncc1CC(C(O)=O)c1cnc[nH]1 |
|---|
| Structure | 
|
|---|
Search and Browse
